When does the presence of the target predict response to the targeted agent?

J Clin Oncol. 2006 Jan 10;24(2):213-6. doi: 10.1200/JCO.2005.03.6913. Epub 2005 Dec 19.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Colorectal Neoplasms / blood supply*
  • Colorectal Neoplasms / drug therapy*
  • Humans
  • RNA, Messenger / analysis
  • Thrombospondins / analysis*
  • Thrombospondins / genetics
  • Vascular Endothelial Growth Factor A / analysis
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*
  • Vascular Endothelial Growth Factor A / genetics

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • RNA, Messenger
  • Thrombospondins
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • thrombospondin 2
  • Bevacizumab